David W Pook
5PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 20, 2023
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study.William K Kelly, Daniel C Danila, Chia-Chi Lin
|Jun 20, 2023
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.David Pook, Daniel M Geynisman, Joan Carles
|Dec 20, 2021
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.Martin R Stockler, Andrew J Martin, Ian D Davis
|Aug 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition.Mitchell G Lawrence, Laura H Porter, Nicholas Choo
|Sep 17, 2020
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer.Robert A Huddart, Arlene O Siefker-Radtke, Arjun V Balar
Pageof 1
Frequent Collaborators
2 joint publications
Shahneen Sandhu
2 joint publications
Miso Kim
2 joint publications
Anthony M Joshua
1 joint publications
Mitchell G Lawrence
1 joint publications
Laura H Porter
1 joint publications
Susanne Ramm
1 joint publications
Andrew Bakshi
1 joint publications
Elaine Sanij
1 joint publications
Christopher J Sweeney
1 joint publications
Ross D Hannan
